CLOs on the Move

Xenon Pharmateuticals

www.xenon-pharma.com

 
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Nathaniel Adams
Senior Director, Legal Affairs Profile
Andrea DiFabio
Chief Legal Officer and Corporate Secretary Profile

Similar Companies

Medical Device Manufacturers Association

Medical Device Manufacturers Association is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Society of Anesthesiologists

The American Society of Anesthesiologists is an educational, research and scientific association of physicians organized to raise the standards of the medical practice of anesthesiology and to improve patient care.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

eNATAL

eNATAL is a Shawnee, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carepartners Health Services

Carepartners Health Services is a Asheville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.